PREPAC-01: Assessment and Prevention of Caregiver Burden in Oncology

Sponsor
Institut Cancerologie de l'Ouest (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05750836
Collaborator
(none)
250
5
2
49
50
1

Study Details

Study Description

Brief Summary

The goal of this randomized, open and controlled supportive care study is to see if we can reduce the burden on the caregiver by offering the caregiver systematic and regular support from the nurse (APN, nurse coordinator in French health care organisations) compared to a support focused on the patient. At the same time, we will also evaluate the impact of this personalised support for the caregiver on their anxiety and quality of life.

Participants will caregivers of a patient who started a line (any line) of systemic treatment for a solid tumour since less than 3 months or in an active palliative situation since less than 1 month.

Researchers will compare 2 groups : a group where caregivers benefit from specific nursing support and a group of caregivers with no specific nursing support.

The specific support includes 3 mandatory on-site nursing consultations with the patient's caregiver and interviews once a month with a nurse either by phone, on-site consultation or teleconsultation.

Condition or Disease Intervention/Treatment Phase
  • Other: Specific nursing support
  • Other: Non-specific nursing support
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
250 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Assessment and Prevention of Caregiver Burden in Oncology
Anticipated Study Start Date :
May 1, 2023
Anticipated Primary Completion Date :
Jan 1, 2027
Anticipated Study Completion Date :
Jun 1, 2027

Arms and Interventions

Arm Intervention/Treatment
Experimental: Arm B

The caregivers benefit from specific nursing support.

Other: Specific nursing support
3 mandatory on-site nursing consultations with the patient's caregiver at inclusion, 6 months and 12 months post-randomisation.The caregivers will complete the questionnaires (Zarit scale, Hospital Anxiety and Depression scale, Medical Outcome Study Short Form - 36, Caregiver's satisfaction). interviews once a month with a nurse either by phone, on-site consultation or teleconsultation. Nurses assess the general health of the caregiver and Identify the socio-professional situation of the caregiver

Active Comparator: Arm A

Caregivers do not receive any specific support from the nurses.

Other: Non-specific nursing support
Caregivers will only have to complete on site Health indicators, Zarit scale, Hospital Anxiety and Depression scale, Medical Outcome Study Short Form - 36 at inclusion, 6 months and 12 months post-randomisation.

Outcome Measures

Primary Outcome Measures

  1. Caregiver burden [at 6 months post-randomisation]

    Comparison in the 2 groups. Burden score is assessed using the ZARIT SCALE. The test consists of 22 questions that the caregiver has to score from 0 to 4, the whole giving a score from 0 to 88. 0 means no burden, 88 means that the burden is severe

Secondary Outcome Measures

  1. The level of anxiety/depression of the caregiver [at month 6 (M6) and month 12 (M12) post-randomisation.]

    Comparaison in the 2 groups. Hospital Anxiety and Depression scale consists of 14 items to which participants respond on a 4-point Likert scale. Seven items assess anxiety and seven items assess depression. Anxiety and depression scores can range from 0 (no symptoms) to 21 (significant presence of symptoms). Threshold scores were determined as follows: between 0 and 7 : no symptoms of anxiety or depression; between 8 and 10 : some moderate symptoms (mild anxiety or depression); score of 11 or more : significant number of symptoms (severe anxiety or depression).

  2. Caregiver's quality of life [at month 6 (M6) and month 12 (M12) post-randomisation.]

    Comparison in the 2 groups. The generic self-questionnaire SF36 consists of 36 items concerning the last four weeks before the test and divided into 8 dimensions (Physical activity ; Life and relationships with others ; Physical pain; Perceived health ; Vitality; Limitations due to the psychological state; Limitations due to the physical state; Psychological health). These eight dimensions are used to measure two summary scores of the quality of life of individuals: the physical composite score (PCS) and the mental composite score (MCS). (score from 0 to 100). A low score reflects a perception of poor health, loss of function, presence of pain. A high score reflects a perception of good health, absence of functional deficit and pain.

  3. Caregiver's satisfaction [at month 6 (M6) and month 12 (M12) post-randomisation.]

    Only arm B. P-GIC questionnaire consists of a single question asking the caregiver about their overall impression of change in specific support care. The caregiver is given the following 8 options and asked to indicate which of these best describes the perceived change: I don't know, Very strongly positive, Strongly positive, Slightly positive, No change, Slightly negative, Strongly negative, Very strongly negative.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Caregiver designated by the patient;

  • Caregiver of a patient who started a line (any line) of systemic treatment for a solid tumour since less than 3 months or in an active palliative situation since less than 1 month;

  • Caregiver of patient already cared for by a nurse before inclusion or going to start a nursing follow-up;

  • Caregiver of a patient with a score ≥2 of social fragility and/or psychological fragility and/or nutritional fragility and/or complexity;

Exclusion Criteria:
  • Patient whose life expectancy is assumed to be < 6 months;

  • Patient living in an institution (EHPAD, MAS, SSR, MCO, USLD) at inclusion;

  • Caregiver declared as having a pathology that could alter his/her capacity to support (psychiatric history, dementia…) or under guardianship.

Contacts and Locations

Locations

Site City State Country Postal Code
1 CH Cholet Cholet France 49300
2 Centre Antoine Lacassagne Nice France 06 189
3 Centre Henri Bequerel Rouen France 76038
4 Institut de Cancérologie de l'Ouest Saint Herblain France 44805
5 CH Mémorial de Saint Lo Saint Lo France 50000

Sponsors and Collaborators

  • Institut Cancerologie de l'Ouest

Investigators

  • Principal Investigator: Céline THOMAS, Nurse, Institut de Cancérologie de l'Ouest

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Institut Cancerologie de l'Ouest
ClinicalTrials.gov Identifier:
NCT05750836
Other Study ID Numbers:
  • ICO-2022-03
First Posted:
Mar 2, 2023
Last Update Posted:
Mar 2, 2023
Last Verified:
Feb 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Institut Cancerologie de l'Ouest
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 2, 2023